PHASE 1 DOSE ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF PF-06804103 IN PATIENTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) POSITIVE SOLID TUMORS
2017-002538-22TUMORES SOLIDOS HER2 POSITIVOSFundación Jiménez DíazInvestigador: MORENO GARCIA VICTOR